Ethzilla Corp. (ETHZ)
NASDAQ: ETHZ
· Real-Time Price · USD
2.42
-0.02 (-0.82%)
At close: Sep 09, 2025, 10:30 AM
Company Description
ETHZilla operates in digital asset management, gaming, and entertainment.
The Company is developing an Ether (ETH) accumulation vehicle to serve as a benchmark for on-chain treasury management among public companies, supported by Electric Capital and a DeFi Council of industry experts.
Its strategy targets yield generation beyond traditional ETH staking while advancing gaming initiatives and pursuing monetization of legacy biotechnology assets from its origins as a biotech company.
Ethzilla Corp.

Country | United States |
IPO Date | Jun 27, 2017 |
Industry | Asset Management - Cryptocurrency |
Sector | Financial Services |
Employees | 4 |
CEO | Lloyd Blair Jordan |
Contact Details
Address: Building 4 Palo Alto, California United States | |
Website | https://180lifesciences.com |
Stock Details
Ticker Symbol | ETHZ |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001690080 |
CUSIP Number | 68236V104 |
ISIN Number | US68236V3024 |
Employer ID | 81-3832378 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Lloyd Blair Jordan L.L.B., M.B.A. | Chief Executive Officer & Director |
Dr. Lawrence Steinman BA, M.D., Ph.D. | Co-Founder & Director |
Eric R. Van Lent | CAO, Principal Accounting & Financial Officer |
Prof. Jagdeep Nanchahal M.D., Ph.D. | Co-Founder & Chairman of Clinical Advisory Board |
Sir Marc Feldman Ph.D. | Co-Founder |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Sep 08, 2025 | 8-K | Current Report |
Sep 05, 2025 | DEF 14A | Filing |
Sep 05, 2025 | 8-K | Current Report |
Sep 02, 2025 | 8-K | Current Report |
Aug 26, 2025 | PRE 14A | Filing |
Aug 25, 2025 | 4 | Filing |
Aug 25, 2025 | 8-K | Current Report |
Aug 25, 2025 | 8-K | Current Report |
Aug 22, 2025 | 424B5 | Filing |
Aug 22, 2025 | S-3ASR | Automatic shelf registration statement of securiti... |